OSTX
OS Therapies Incorporated Common Stock
$1.840+-0.000 (-0.000%)
即時價格
價格圖表
Loading Chart...
關鍵指標
市場指標
開盤
$1.840
最高
$1.840
最低
$1.840
交易量
0.08M
公司基本面
交易統計
相關新聞
PR Newswire
OS Therapies Partners with EVERSANA for the U.S. Commercialization of OST-HER2 in Recurrent, Fully Resected, Pediatric Lung Metastatic Osteosarcoma
OS Therapies Inc. (NYSE-A: OSTX) ("OS Therapies" or "the Company"), a clinical-stage cancer immunotherapy and antibody drug conjugate biotechnology...
查看更多
Analyst Upgrades
D. Boral Capital Maintains Buy on OS Therapies, Maintains $20 Price Target
D. Boral Capital analyst Jason Kolbert maintains OS Therapies with a Buy and maintains $20 price target.
查看更多
BusinessWire
OS Therapies Submits Request for Regenerative Medicine Advanced Therapy (RMAT) Designation to U.S. FDA for OST-HER2 in the Prevention of Metastases in Recurrent, Fully-Resected, Lung Metastatic Pediatric Osteosarcoma
If awarded, OST-HER2 would become the first listeria investigational medicinal product to be awarded the RMAT designation RMAT designation reduces BLA application review time and permits augmented interactions with
查看更多
